BioSpace News Archive

ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today highlighted key updates from its oral presentation at the 5th International Conference on Base Editing, Prime Editing & Related Enzymes (Deaminet 2024) in San Diego, California.

Optimi Health Corp. is pleased to announce it has been granted an amendment to its Health Canada Controlled Drugs and Substances Licence.

MedBright AI Investments Inc. (the “Company” or “MedBright”) (CSE:MBAI, OTCQB:MBAIF, FSE:1V7) has announced today that they will be presenting at both the CEM Bahamas Small-Cap Conference, and Maxim Group’s 2024 Healthcare IT Conference in the upcoming week.

Bionano Genomics, Inc (Nasdaq: BNGO) today announced its 2024 Symposium lineup of 33 oral presentations delivered by 26 different customers worldwide featuring the utility of optical genome mapping (OGM) across a wide range of research applications in cancer, cell and gene therapy, and genetic disease.

Vaxart, Inc. (Nasdaq: VXRT) today announced that the United States Biomedical Advanced Research and Development Authority (BARDA) has awarded the Company $9.27 million to fund preparation for a 10,000 subject Phase 2b clinical study evaluating Vaxart’s oral pill XBB COVID-19 vaccine candidate against an approved mRNA vaccine comparator.

Edgewise Therapeutics, Inc. today announced the pricing of an underwritten offering of 21,818,182 shares of its common stock at an offering price of $11.00 per share.

Biomimetic Innovations Ltd today announced that OsStic ® has been granted ‘Breakthrough Device’ designation by the FDA.

STEMCELL Technologies is pleased to announce the acquisition of Propagenix Inc.

Tampa General Hospital announced that the TGH Cancer Institute recently completed Florida’s first successful infusion of Hemgenix, a gene therapy option for patients with severe hemophilia B — a rare bleeding disorder characterized by failure of the blood to clot properly.

The presentation will focus on the use of mRNA in Liquid Biopsies as a platform for precision diagnostics